SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-031752
Filing Date
2023-11-14
Accepted
2023-11-14 07:15:14
Documents
14
Period of Report
2023-11-14
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bcda20231113_8k.htm   iXBRL 8-K 25540
2 EXHIBIT 99.1 ex_596726.htm EX-99.1 12632
  Complete submission text file 0001437749-23-031752.txt   190531

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bcda-20231114.xsd EX-101.SCH 3874
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20231114_def.xml EX-101.DEF 13417
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20231114_lab.xml EX-101.LAB 17617
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20231114_pre.xml EX-101.PRE 13394
8 EXTRACTED XBRL INSTANCE DOCUMENT bcda20231113_8k_htm.xml XML 4323
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38999 | Film No.: 231401562
SIC: 2836 Biological Products, (No Diagnostic Substances)